Table 2.
The relationship between NLR, LMR, and neurological deterioration.
| Variables | Unadjusted | Adjusted | ||
|---|---|---|---|---|
| OR (95%CI) | p Value | OR (95%CI) | p Value | |
| WBC | 1.132 (1.086–1.179) | <0.001 | 1.126 (1.074–1.180) | <0.001 |
| ALC | 0.216 (0.144–0.325) | <0.001 | 0.210 (0.134–0.328) | <0.001 |
| ANC | 1.166 (1.116–1.219) | <0.001 | 1.162 (1.105–1.223) | <0.001 |
| AMC | 0.910 (0.730–1.135) | 0.403 | 0.994 (0.756–1.307) | 0.965 |
| NLR | 1.143 (1.110–1.176) | <0.001 | 1.142 (1.107–1.179) | <0.001 |
| LMR | 0.677 (0.599–0.765) | <0.001 | 0.664 (0.597–0.760) | <0.001 |
Adjusted by age, sex, initial GCS, systolic and diastolic BP, systolic and diastolic BP variability, BP-lowering strategy, types of BP-lowering agents, unhealthy lifestyle including smoking and drinking, baseline ICH volume, time from stroke onset to blood sample, presence of intraventricular hemorrhage, hematoma location, hematoma expansion, and presence of spot sign and infection.